Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.

SNPHY
Santen Pharmaceutical Co., Ltd.US flagOther OTC
11.80
USD
-0.13
- -
3.80BMarket Cap

Santen Pharmaceutical Co., Ltd. (SNPHY) Stock Splits

Learn about Santen Pharmaceutical Co., Ltd.'s most recent 2499-for-1000 basis stock split on April 02, 2015. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Santen Pharmaceutical Co., Ltd.'s most recent stock split

Split Date: 2015-04-02
Split Ratio: 2499:1000
Price Before Split: $35.61
Price After Split: $14.25

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 2.50 times more shares (a 2499:1000 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Santen Pharmaceutical Co., Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2015-04-022499:1000No$35.61$14.25

About Santen Pharmaceutical Co., Ltd.

Company overview and industry information

Santen Pharmaceutical Co., Ltd. (SNPHY) operates in the Drug Manufacturers - General industry. The recent 2499-for-1000 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - General
Go to Santen Pharmaceutical Co., Ltd. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.